Brief: Poxel End-March Cash And Cash Equivalents Down At 36.9 Million Euros

Poxel SA

21/04/2020 17:45

April 21 (Reuters) - POXEL SA  POXEL.PA :
    * POXEL ANNOUNCES FIRST QUARTER 2020 FINANCIAL AND CORPORATE
UPDATE
    * STRENGTHENED CASH POSITION IN MARCH 2020; DREW DOWN EUR 10
MILLION FROM IPF PARTNERS BOND LOAN
    * AS OF MARCH 31, 2020, CASH AND CASH EQUIVALENTS WERE EUR
36.9
MILLION (USD 40.4 MILLION), AS COMPARED TO EUR 37.2 MILLION (USD
41.8 MILLION) AS OF DECEMBER 31, 2019
    * POXEL REPORTED REVENUES OF EUR 1.5 MILLION FOR THE QUARTER
ENDED
MARCH 31, 2020
    * METAVANT MET WITH U.S. FOOD AND DRUG ADMINISTRATION (FDA)
IN Q1
2020
    * CONTINUES TO WORK WITH SUMITOMO DAINIPPON PHARMA ON
ACTIVITIES
RELATED TO THE JNDA SUBMISSION FOR THE TREATMENT OF TYPE 2
DIABETES, WHICH IS ANTICIPATED IN THE THIRD QUARTER OF 2020,
WITH A TARGET LAUNCH IN 2021
    * PXL770 (NASH): RESULTS FROM PHASE 2A TRIAL ARE CURRENTLY
EXPECTED LATE Q3 OF 2020

Source text for Eikon:  ID:nBw1C4PfWa 
Further company coverage:  POXEL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))